Genome & Company announced a private placement of 1,871,921 convertible preferred shares at a price of KRW18,350 for gross proceeds of KRW 34,349,750,350 on August 18, 2022. The funding is being raised through third party allotment method. The transaction has been approved by the board of directors of the company. The transaction is expected to close on September 19, 2022. The preferred shares are convertible in to common shares during the period from September 20, 2023 - September 19, 2027.

On August 18, 2022, the transaction is expected to close on September 2, 2022.The 844,677 preferred shares are convertible in to common shares during the period from September 3, 2023 - September 3, 2027. The transaction included participation from other investors Industrial Bank of Korea (in the position of trustees of the Value System New Deal General Private Equity Investment Trust) for 54,495 shares, Industrial Bank of Korea (in the position of trustee of the Value System New Deal General Private Equity Investment Trust No. 2) for 54,495 shares, Mirae Asset Securities Co., Ltd. (in the position of trustee of the Mercury Kosdak Venture T2 General Private Equity Trust) for 38,147 shares, KB Securities Co., Ltd. (in the position of trustee of the Mercury Kosdak Venture T4 General Private Equity Trust) for 16,348 shares, Korea Securities Finance Corporation (in the position of trustee of the Welcome Offering Kosdak Venture Company Securities Investment Trust [Stock Mixed-Derivative]) for 38,147 shares, Korea Securities Finance Corporation (in the position of trustee of the Welcome Kosdak Venture Offering Juritz Securities Investment Trust [Stock Mixed-Derivative]) fot 43,596 shares, Korea Securities Finance Corporation (in the position of trustee of the Welcome Offering Kosdak Venture Securities Investment Trust No. 5 [Stock Mixed-Derivative]) fot 16,348 shares, Shinhan Bank (in the position of trustee of the Welcome Offering Kosdak Venture Securities Investment Trust No. 3 [Share-Mixed-Derivative]) for 38,147 shares, Shinhan Bank (in the position of trustee of the Welcome Offering Kosdak Venture Securities Investment Trust No. 4 [Share-Mixed-Derivative]) for 27,247 shares, BTC Investment for 54,495 shares, BTCI 2021 Pef 1 for 163,487 shares, SEMA Public Technology Commercialization Fund for 54,495 shares, IMM Salus Venture Fund 1 for 163,487 shares and returning investor Korea Investment & Securities Co., Ltd. for 81,743 shares.